University of Adelaide, Australia
Timothy P. Hughes, MD, FRACP, FRCPA, MBBS, FAAHMS
Professor Timothy Hughes is the Precision Medicine Theme Leader at the South Australian Health and Medical Research Institute (SAHMRI); Beat Cancer Professor at the University of Adelaide and Consultant Haematologist at the Royal Adelaide Hospital. He is also Chair of the International Chronic Myeloid Leukemia Foundation (iCMLf) and an inaugural Fellow of the Australian Academy of Health and Medical Sciences (AAHMS).
Professor Hughes is an international expert in the biology and treatment of leukaemia. Professor Hughes had a significant leadership role in the establishment of the molecular response criteria and kinase domain mutation screening guidelines that are used world-wide to monitor response and resistance in chronic myeloid leukaemia (CML). He has been a principal investigator on many of the key Global and Australian CML trials that have shaped the way tyrosine-kinase inhibitors (TKIs) are selected and sequenced. He has been a leader in the area of treatment-free remission (TFR) and influential in the recent recommendations to make TFR a mainstream goal of therapy. He has published over 300 papers with over 49,000 citations.